REQUEST A DEMO
Total
USD $0.00
Search more companies

Aaragon Pharma S.R.O. (Czech Republic)

Main Activities: Real Estate
Full name: Aaragon Pharma S.R.O. Profile Updated: November 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Aaragon Pharma S.R.O. is a company in Czech Republic, with a head office in Hostivice. The enterprise operates in the Real Estate industry. Aaragon Pharma S.R.O. was incorporated on March 03, 2020. The company’s latest financial report indicates a net sales revenue increase of 754.73% in 2022. Its’ total assets recorded a growth of 195.4%. The net profit margin of Aaragon Pharma S.R.O. decreased by 4.42% in 2022.

Headquarters
Palouky 1366
Hostivice; Stredocesky; Postal Code: 25301

Contact Details: Purchase the Aaragon Pharma S.R.O. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Aaragon Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Aaragon Pharma S.R.O. report to view the information.
Incorporation Date:
March 03, 2020
Key Executives
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Aaragon Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
754.73%
Total operating revenue
754.73%
Operating profit (EBIT)
-8.48%
EBITDA
5.65%
Net Profit (Loss) for the Period
-35.83%
Total assets
195.4%
Total equity
687.59%
Operating Profit Margin (ROS)
-4.77%
Net Profit Margin
-4.42%
Return on Equity (ROE)
-984.23%
Quick Ratio
0.09%
Cash Ratio
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?